$145.32
$-1.40 (-0.95%)
End-of-day quote: 04/17/2024
NasdaqGS:ALNY

Alnylam Pharmaceuticals Inc Stock Price

0
Underperform
1
2
3
4
5
6
7
8
9
10
1M 3M YTD 1Y 2Y 5Y 10Y 20Y
P/E Ratio
0.0
Market Cap
18.38B
Price-to-book Ratio
0
Earnings
05/03/2024
Dividend
$0.00
Div Yld
0.00%
Dividend Growth
0 Years
Beta
0.40
Short Interest
3.19%
Forecast 1Y
0.00%
Analyst Price Target
$245.24
LTG 5Y
0.00%
52 week range
$143.52 - $218.88